Healthcare >> CEO Interviews >> November 17, 2008
DR. JAMES S. KUO is Chairman of the Board and Chief Executive Officer of Duska
Therapeutics, Inc. Previously, he was Chairman and Chief Executive Officer of
BioMicro Systems, Inc., a private, venture-backed and profitable research tools
company. While at BioMicro, he led distribution, marketing and sales of the
company's MAUI product line. Prior to that time, Dr. Kuo was President, and
Chief Executive Officer of Discovery Laboratories, Inc., where he raised over
$22 million in initial private funding and took the company public. Dr. Kuo is
the former Managing Director of Venture Analysis for HealthCare Ventures, LLC,
which managed $378 million in venture funds. He has also been a senior
pharmaceutical licensing and development executive at Pfizer, Inc., and Vice
President of Business Development at Myriad Genetics, Inc. Dr. Kuo is a Board
Director of Monarch Labs, LLC, Chairman of the Board of DOR BioPharma, Inc., and
a Board Director of Adeona Pharmaceuticals, Inc. After studying molecular
biology and receiving his BA at Haverford College, Dr. Kuo simultaneously
received his MD from The University of Pennsylvania School of Medicine and his
MBA from The Wharton School of Business at the University of Pennsylvania. Profile
Dr. Kuo: Duska Therapeutics is a publicly traded biotechnology company that
focuses on the clinical development of new cardiovascular
